FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Paytm IPO and Windlas Biotech IPO.
Paytm IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Paytm IPO | Windlas Biotech IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Citigroup Global Markets India Private Limited Goldman Sachs (India) Securities Private Limited Hdfc Bank Limited ICICI Securities Limited J.P. Morgan India Private Limited Morgan Stanley India Company Pvt Ltd |
Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Iifl Securities Ltd SBI Capital Markets Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Paytm IPO is up to ₹18,300.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Paytm IPO is ₹2,150.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
Paytm IPO | Windlas Biotech IPO | |
---|---|---|
Face Value | ₹1 per share | ₹5 per share |
Issue Price (Lower) | ₹2,080.00 per share | ₹448.00 per share |
Issue Price (Upper) | ₹2,150.00 per share | ₹460.00 per share |
Issue Price (Final) | ₹2,150.00 per share | ₹460.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 6 shares | 30 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹8,300.00 Cr | up to ₹165.00 Cr |
OFS Issue Size | 51,42,067 shares | |
OFS Issue Size (Amount) | up to ₹10,000.00 Cr | up to ₹236.54 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹18,300.00 Cr | up to ₹401.54 Cr |
Paytm IPO opens on Nov 08, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Paytm IPO and Windlas Biotech IPO is Nov 10, 2021, and Aug 06, 2021, respectively.
Paytm IPO | Windlas Biotech IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Nov 08, 2021 | Aug 04, 2021 |
Issue Close | Nov 10, 2021 | Aug 06, 2021 |
Basis Of Allotment (Tentative) | Nov 15, 2021 | Aug 11, 2021 |
Initiation of Refunds (Tentative) | Nov 16, 2021 | Aug 12, 2021 |
Credit of Share (Tentative) | Nov 17, 2021 | Aug 13, 2021 |
Listing date (Tentative) | Nov 18, 2021 | Aug 16, 2021 |
Anchor Lockin End date 1 | Dec 15, 2021 | Sep 10, 2021 |
Anchor Lockin End date 2 | Feb 13, 2022 | Nov 09, 2021 |
Paytm IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
Paytm IPO | Windlas Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 78% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 65.16% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Paytm IPO retail investors (RII) are offered 87,98,076 shares while in Windlas Biotech IPO retail investors are offered 87,98,076 shares. Qualified institutional buyers (QIB) are offered 2,63,94,231 shares in Paytm IPO and 17,23,700 shares in Windlas Biotech IPO.
Paytm IPO | Windlas Biotech IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 2,63,94,231 shares | 17,23,700 shares |
NII | 1,31,97,115 shares | 13,23,766 shares |
RII | 87,98,076 shares | 30,88,786 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 4,83,89,422 shares | 61,36,252 shares |
Paytm IPO subscribed 1.89x in total, whereas Windlas Biotech IPO subscribed 22.44x.
Paytm IPO | Windlas Biotech IPO | |
---|---|---|
QIB (times) | 2.79x | 24.40x |
NII (times) | 0.24x | 15.73x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.66x | 24.22x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.89x | 22.44x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|